Edition:
United States

Novelion Therapeutics Inc (NVLN.OQ)

NVLN.OQ on NASDAQ Stock Exchange Global Select Market

1.15USD
3:59pm EST
Change (% chg)

$-0.01 (-0.86%)
Prev Close
$1.16
Open
$1.14
Day's High
$1.16
Day's Low
$1.06
Volume
29,543
Avg. Vol
285,107
52-wk High
$5.86
52-wk Low
$0.70

Revenue & Earnings Per Share

    Revenue* Earnings Per Share**
FY 2018 Sep '18 30.33 -1.316
Jun '18 31.90 -1.667
Mar '18 27.48 -1.755
FY 2017 Dec '17 38.91 -1.316
Sep '17 28.67 -2.668
Jun '17 40.88 -1.152
Mar '17 29.98 -1.670
FY 2016 Dec '16 13.57 -1.482
Sep '16 0.00 -0.562
Jun '16 0.00 -0.485
Mar '16 0.00 -2.072
 
*Note: Units in Millions ofU.S. Dollars
**Note: Units in U.S. Dollars

Consensus Estimates Analysis

  # of Estimates Mean High Low 1 Year Ago
SALES (in millions)
Quarter Ending Dec-18 1 40.90 40.90 40.90 --
Year Ending Dec-18 1 130.60 130.60 130.60 155.00
Year Ending Dec-19 1 146.90 146.90 146.90 189.20
Earnings (per share)
Quarter Ending Dec-18 1 -0.90 -0.90 -0.90 --
Year Ending Dec-18 1 -5.63 -5.63 -5.63 -3.40
Year Ending Dec-19 1 -3.64 -3.64 -3.64 -0.43
Sales and Profit Figures in US Dollar (USD);

Valuation Ratios

  Company industry sector
P/E Ratio (TTM) -- 95.96 30.88
P/E High - Last 5 Yrs. -- 287.89 46.69
P/E Low - Last 5 Yrs. -- 90.15 25.78
Beta 1.80 0.66 0.95
Price to Sales (TTM) 0.14 242.95 21.76
Price to Book (MRQ) -- 18.87 4.53
Price to Tangible Book (MRQ) -- 22.13 11.76
Price to Cash Flow (TTM) -- 54.67 22.24
% Owned Institutions -- 0.00 0.00

Dividends

  Company industry sector
Dividend Yield -- 0.39 1.60
Dividend Yield - 5 Year Avg -- 0.20 1.42
Dividend 5 Year Growth Rate -- 3.31 -8.76
Payout Ratio(TTM) -- 6.79 44.03

Growth Rates

  Company industry sector
Sales (MRQ) vs Qtr. 1 Yr. Ago 5.81 156.34 6.54
Sales (TTM) vs TTM 1 Yr. Ago 13.73 61.53 5.26
Sales - 5 Yr. Growth Rate -- 24.06 7.59
EPS (MRQ) vs Qtr. 1 Yr. Ago 50.67 196.06 22.50
EPS (TTM) vs TTM 1 Yr. Ago 13.17 -- --
EPS - 5 Yr. Growth Rate -- 23.46 7.64
Capital Spending - 5 Yr. Growth Rate -3.31 37.07 8.38

Financial Strength

  Company industry sector
Quick Ratio (MRQ) 0.17 3.57 2.63
Current Ratio (MRQ) 0.22 6.87 3.68
LT Debt to Equity (MRQ) -- 16.70 9.53
Total Debt to Equity (MRQ) -- 21.89 13.39
Interest Coverage (TTM) -2.65 -289.65 33.85

Profitability Ratios

  Company industry sector
Gross Margin (TTM) 54.34 31.33 50.91
Gross Margin - 5 Yr. Avg. -- 47.59 52.22
EBITD Margin (TTM) -27.90 -- --
EBITD - 5 Yr. Avg -118.62 -141.70 16.27
Operating Margin (TTM) -50.58 -1,638.83 -15.11
Operating Margin - 5 Yr. Avg. -117.86 -155.53 11.89
Pre-Tax Margin (TTM) -87.31 -1,574.14 -13.67
Pre-Tax Margin - 5 Yr. Avg. -151.93 -157.11 12.22
Net Profit Margin (TTM) -88.21 -1,572.92 -17.11
Net Profit Margin - 5 Yr. Avg. -152.90 -158.05 8.44
Effective Tax Rate (TTM) -- 15.93 21.73
Effective Tax Rate - 5 Yr. Avg. -- 19.64 24.41

Efficiency

  Company industry sector
Revenue/Employee (TTM) 714,611 28,103,806 878,349,382
Net Income/Employee (TTM) -630,367 -3,710,889 102,474,711
Receivable Turnover (TTM) 7.13 9.19 5.49
Inventory Turnover (TTM) 3.37 2.64 3.99
Asset Turnover (TTM) 0.35 0.46 0.93

Management Effectiveness

  Company industry sector
Return on Assets (TTM) -30.95 0.35 11.06
Return on Assets - 5 Yr. Avg. -17.40 2.90 11.85
Return on Investment (TTM) -83.30 0.60 13.80
Return on Investment - 5 Yr. Avg. -19.90 2.87 15.17
Return on Equity (TTM) -- -2.18 15.29
Return on Equity - 5 Yr. Avg. -29.31 -0.88 16.29
  1 Year 3 Year 5 Year
Sales % 919.88 -- --
EPS (TTM) % -45.27 -- --
Dividend % -- -- --
Note: Units in Millions of US Dollars

Performance for Novelion Therapeutics Inc

Period %
Actual
% vs.
S&P 500
Rank In
Industry
Industry
Rank
4 Week 9.51 9.53 99 99
13 Week -74.59 -72.55 5 94
26 Week -76.94 -76.88 9 96
52 Week -76.83 -77.53 17 98
YTD -70.52 -70.61 23 94
Note:: Rank is a percentile that ranges from 0 to 99, with 99 = best.

Institutional Holders

% Shares Owned: 71.03%
# of Holders: 59
Total Shares Held: 13,447,800
3 Mo. Net Change: -1,166,353
# New Positions: 5
# Closed Positions: 11
# Increased Positions: 12
# Reduced Positions: 28
# Net Buyers: -16
NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.